Author

Monica M. Cho

University of Wisconsin–MadisonORCID 0000-0002-6708-9578Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Assay:flow cytometry· 1 Organism:mouse· 1 Organism:non-human primate· 1 Assay:proteomics· 1

Frequent Co-Authors

Christian M. CapitiniiD· 2 shared Aicha E. QuamineiD· 1 shared Allison M. WeisnichtiD· 1 shared Anastasia A Griggs· 1 shared Bryon D. JohnsoniD· 1 shared Chloe A King· 1 shared David M. VailiD· 1 shared Evan L. DrayiD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Christian M. CapitiniORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintMar 23, 2026

Safety and Feasibility of Infusing Ex Vivo Expanded Allogeneic Canine Natural Killer Cells for the Treatment of Metastatic Solid Tumors

Allison M. Weisnicht, Fernanda Szewc, Monica Moonkyung Cho…·Christian M. Capitini

This study expands and activates allogeneic canine NK cells ex vivo, demonstrating their safety and in vitro potency for treating metastatic solid tumors.

DOI 10.64898/2026.03.19.712729

non-human primateflow cytometry

𝕏 PostBluesky

ImmunologyJournal for ImmunoTherapy of CancerPeer-reviewedDec 1, 2025

TIM-3 blockade enhances ex vivo stimulated allogeneic NK cell therapy for relapsed murine neuroblastoma after hematopoietic cell transplant

Aicha E. Quamine, Evan L. Dray, Nicholas R Mohrdieck…·Christian M. Capitini

This study shows that combining TIM-3 blockade with ex vivo stimulated allogeneic NK cells improves survival and reduces tumor growth in a murine neuroblastoma model after allo-HCT without increasing GVHD.

2 citations

mouseproteomics

𝕏 PostBluesky